Is repeated low-level red-light therapy (RLRL) the next big thing in myopia control? Join Prof. Mingguang He from The Hong Kong Polytechnic University as he discusses his work on the efficacy, safety and future of RLRL—and why he thinks it’s brighter than ever.
RLRL is an at-home, low-level laser treatment that leverages the therapeutic properties of red light to influence axial length growth. The body of evidence supporting its use to control axial length growth in myopia is growing—so head to the Eyerising International website (https://www.eyerisinginternational.com/) to learn more about the latest research on RLRL and the Eyerising Myopia Management Device.
